XML 23 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:    
Net earnings $ 6,636 $ 7,878
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:    
Depreciation and amortization 3,184 2,305
Provision for credit losses 120 227
Stock-based compensation expense 1,071 665
Deferred income taxes (1,982) 191
Accrued payment in kind ("PIK") interest 463 0
Change in assets and liabilities (net of effect of acquisition):    
Receivables (1,825) 4,745
Inventories 2,862 44
Accounts payable and other accrued expenses (4,925) (3,842)
Deferred revenue 2,464 6,151
Other, net (2,692) 55
Net cash provided by operating activities 5,376 18,419
Cash flows from investing activities:    
Capital expenditures (1,650) (3,394)
Purchase of business, net of cash acquired (28,735) 0
Net cash used in investing activities (30,385) (3,394)
Cash flows from financing activities:    
Dividends paid to non-controlling interest in subsidiaries (161) 0
Proceeds from term loan 15,000 0
Repayments on term loan (500) 0
Proceeds from short-term borrowings 72,191 112,316
Repayments on short-term borrowings (74,158) (112,718)
Payments on sale-leaseback financing transaction (529) (476)
Proceeds from long-term lease obligations 0 202
Payments on long-term lease obligations (94) (78)
Purchase of treasury stock 0 (791)
Net cash provided by (used in) financing activities 11,749 (1,545)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (343) (183)
(Decrease) increase in cash, cash equivalents and restricted cash (13,603) 13,297
Cash, cash equivalents and restricted cash, beginning of period 25,938 13,815
Cash, cash equivalents and restricted cash, end of period 12,335 27,112
Supplemental Disclosure of Cash Flow Information    
Interest 1,532 1,248
Noncash investing and financing activities:    
Change in debt related to seller note $ 23,000 $ 0